Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus
about
Can administration of potentized homeopathic remedy, Arsenicum album, alter antinuclear antibody (ANA) titer in people living in high-risk arsenic contaminated areas? I. A correlation with certain hematological parameters.Primary cardiac disease in systemic lupus erythematosus patients: protective and risk factors--data from a multi-ethnic Latin American cohort.Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort.Prognostically distinct clinical patterns of systemic lupus erythematosus identified by cluster analysis.Chinese SLE treatment and research group registry: III. association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus.Clinical and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian populationTwo major autoantibody clusters in systemic lupus erythematosusEuropean League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies[Headache and systemic lupus erythematosus: prevalence and associated conditions].Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort.Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosusBAFF and MyD88 signals promote a lupuslike disease independent of T cells.Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.Systemic lupus erythematosus and Raynaud's phenomenon.The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression.Autoantibody detection using multiplex technologies.Autoantibodies from mice exposed to Libby amphibole asbestos bind SSA/Ro52-enriched apoptotic blebs of murine macrophagesCharacterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register.Evaluation of C1q genomic region in minority racial groups of lupus.Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling.Clinical associations with autoantibody reactivities to individual components of U1 small nuclear ribonucleoprotein.Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity.Clinical aspects of indirect immunofluorescence for autoimmune diseases.Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.How should a district general hospital immunology service screen for anti-nuclear antibodies? An 'in-the-field' audit.A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.Antinuclear antibody testing - misunderstood or misbegotten?A Child's HLA-DRB1 genotype increases maternal risk of systemic lupus erythematosus.Ribosomal P antibody: 30 years on the road.Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese.Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation.Cytokine and autoantibody clusters interaction in systemic lupus erythematosus.Clinicopathological study of male and female patients with lupus nephritis: a retrospective study.Clinical & immunological characteristics in systemic lupus erythematosus patients.Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities.TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development.The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus
P2860
Q25257686-2F091831-E455-4427-B317-C4199B349F33Q30778909-6D7FAFDB-9503-4A4A-BA37-CA4F4DDAC046Q33380972-0E9B97D7-5970-4BC1-BCB1-C44A4E222ACCQ33386818-E667DEEC-282E-4E0C-A587-1DF4406C571DQ33597476-A4B5AF27-F0FC-44F5-A22C-AAFD729ADD7DQ34056359-D711A863-B68C-4C5B-86F6-27832F2F7B6BQ34171558-E482D8FE-CA1F-4BEF-95C0-28CF965BA7BEQ34187282-81820C09-B5BC-472A-A522-B89802348C2EQ34762298-29F6AFEB-2423-4665-A441-B78EB842EA86Q35762748-28228FAB-1B36-4EFA-A5CD-3EF85C2F60CBQ35825371-E6892041-3454-4582-B2EF-6E57871B181DQ36229560-688F1AB0-EEF5-4761-9F58-5533FED99588Q36375513-A80D0276-E450-4BE6-9359-665E65D1EC2EQ36398289-2FE6C8FC-2261-4D9F-8C04-138EB2C83941Q36404735-E9C5578C-F45C-4BA4-BC39-315F9EFEA979Q36560781-762311F2-E50F-4154-822D-45F515C8BE11Q36593698-108A49BE-F5DD-41A6-B0D3-E756372AE8EBQ36663933-282E77F5-32FC-4DFE-AB4A-2438C2630DCEQ37256378-9D3EA395-BD4E-4E8B-B110-4CCE89DB4422Q37403645-44268E6B-7B0C-497E-A37F-17648E3E8111Q37453484-7765A9B0-1BB8-425F-A2E0-F294C36746ECQ37656861-746F0B57-2A1E-4A1A-BB9D-301450D8771EQ38099772-9734670F-F6FE-4679-BA48-3DD6E76A4CD8Q38382986-F0BB231A-D902-47A0-AFB7-6DA31525E69FQ38883608-E732AB4F-8105-4B6F-9E88-245E6407AE8BQ38938849-B89948DB-875C-4EEA-9123-D10125B5F85EQ39247284-47368286-1899-4F59-89AF-AD2C59FA86CBQ39328604-D649E3CC-751F-4E29-942A-F6AAEC106A2DQ39624051-07EE5438-C318-4AE0-8B83-715C4DEAB016Q40250609-865E7AA7-C5AC-4F60-8B44-40F5B19BA202Q44234667-26904B37-F03F-4952-9169-6CD81C28DA7EQ44436037-7FA445A1-A8A0-4A87-A1C9-435C2C4CCDA9Q47120444-A2A6B441-D9CD-4777-B6A9-F0779A7EB584Q47211298-53F21B97-D03B-4DAB-B580-1D762181C26EQ47267228-DAC202B5-37AE-4FEC-875E-C7D35FE95972Q47603082-C2600B43-D66F-4E10-9A7A-F820A4798A2FQ50850816-4FDD0A6B-93C4-454E-9D6F-2347B543D4CBQ54766883-1FAB32BF-CA86-447A-87AC-C478DD60C2E6Q59034615-FA98A525-15F4-4BBA-97A7-2E4F91EA9D7D
P2860
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Specific antinuclear antibodie ...... n systemic lupus erythematosus
@ast
Specific antinuclear antibodie ...... n systemic lupus erythematosus
@en
type
label
Specific antinuclear antibodie ...... n systemic lupus erythematosus
@ast
Specific antinuclear antibodie ...... n systemic lupus erythematosus
@en
prefLabel
Specific antinuclear antibodie ...... n systemic lupus erythematosus
@ast
Specific antinuclear antibodie ...... n systemic lupus erythematosus
@en
P2093
P356
P1476
Specific antinuclear antibodie ...... n systemic lupus erythematosus
@en
P2093
Cebecauer L
De Bosschere K
De Keyser F
Hoffman IE
Huizinga TW
Hulstaert F
P304
P356
10.1136/ARD.2003.013417
P407
P577
2004-09-01T00:00:00Z